Conflict of interest: Professor Rozenman has received consulting or lecture fees from Abbott Vascular, Boston Scientific, Medtronic, Pfizer, Sanofi-Aventis, Merck, Eli-Lilly, and AstraZeneca. Drs. Mehran and Dangas have received grant support from BMS/Sanofi-Aventis, consulting or lecture fees from Cordis and The Medicines Company, and serve on Advisory Boards for Abbott Vascular, Cardiva, and Regado Biosciences. Dr. Witzenbichler has received lecture fees from The Medicines Company and Boston Scientific. Dr. Stone serves on Advisory Boards for Abbott Vascular and Boston Scientific and has received consulting fees from The Medicines Company, Eli Lilly, Merck, AstraZeneca, and Bristol-Meyers-Squibb. The other authors have no financial disclosures to report.
Coronary Artery Disease
Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction†
Article first published online: 17 APR 2012
Copyright © 2012 Wiley Periodicals, Inc.
Catheterization and Cardiovascular Interventions
Volume 81, Issue 1, pages E9–E14, 1 January 2013
How to Cite
Rozenman, Y., Mehran, R., Witzenbichler, B., Dangas, G., Desaga, M., Kochman, J., Nilsen, D. W., Finkelstein, A., Mosseri, M. and Stone, G. W. (2013), Relationship between the intensity of heparin anticoagulation and clinical outcomes in patients receiving glycoprotein IIb/IIIa inhibitors during primary percutaneous coronary intervention in acute myocardial infarction. Cathet. Cardiovasc. Intervent., 81: E9–E14. doi: 10.1002/ccd.24279
- Issue published online: 21 DEC 2012
- Article first published online: 17 APR 2012
- Manuscript Accepted: 25 NOV 2011
- Manuscript Revised: 16 JUL 2011
- Manuscript Received: 23 MAY 2011
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.